Oklahoma § 63-2-112 Report on progress of opioid act of 2019.

Oklahoma Statutes

§ 63-2-112 — Report on progress of opioid act of 2019.

Oklahoma § 63-2-112

Title 63Public Health And Safety

This text of Oklahoma § 63-2-112 (Report on progress of opioid act of 2019.) is published on Counsel Stack Legal Research, covering Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Okla. Stat. tit. 63, § 63-2-112 (2026).

Text

The Oklahoma State Bureau of Narcotics and Dangerous Drugs Control shall report to the standing committees of the Legislature having jurisdiction over health and human services matters and over occupational and professional regulation matters, no later than January 31, 2020, with progress on implementing the provisions of this act. The report shall contain, at a minimum, the following information: 1. Registration of prescribers and dispensers in the central repository pursuant to Section 2-309A et seq. of Title 63 of the Oklahoma Statutes; 2. Data regarding the checking and using of the central repository by data requesters; 3. Data from professional boards regarding the implementation of continuing education requirements for prescribers of opioid drugs; 4. Effects on the prescriber workfo

Free access — add to your briefcase to read the full text and ask questions with AI

The Oklahoma State Bureau of Narcotics and Dangerous Drugs Control shall report to the standing committees of the Legislature having jurisdiction over health and human services matters and over occupational and professional regulation matters, no later than January 31, 2020, with progress on implementing the provisions of this act. The report shall contain, at a minimum, the following information: 1. Registration of prescribers and dispensers in the central repository pursuant to Section 2-309A et seq. of Title 63 of the Oklahoma Statutes; 2. Data regarding the checking and using of the central repository by data requesters; 3. Data from professional boards regarding the implementation of continuing education requirements for prescribers of opioid drugs; 4. Effects on the prescriber workforce; 5. Changes in the numbers of patients taking more than one hundred (100) morphine milligram equivalents of opioid drugs per day; 6. Data regarding the total quantity of opioid drugs prescribed in morphine milligram equivalents; 7. Progress on electronic prescribing of opioid drugs; and 8. Improvements to the central repository through the request for proposals process including feedback from prescribers, dispensers and applicable state licensing boards on those improvements.